GARY S JACOB
CIK 1266802 · Chief Executive Officer · last filed 2024-02-21
GARY S JACOB is a Chief Executive Officer who has filed 54 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for HEPA, was dated Feb 21, 2024. Across all open-market trades the lifetime net is +$163.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $53.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$53.7K
10
54
$163.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HEPA | Director | 12,059 | $0.08 | $965 | $19.9K | 6 | 2024-02-21 |
| OKYO | Chief Executive Officer | 12,500 | $1.52 | $19.0K | $50.0K | 1 | 2022-05-19 |
| VRPX | Director | 3,500 | $0.00 | $1 | $23.8K | 3 | 2022-01-05 |
| CRDF | Director | 21,922 | $1.54 | $33.8K | $49.7K | 4 | 2021-06-15 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | 148,954 | — | — | $0 | 5 | 2019-06-24 |
| Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Director | — | — | — | $0 | 2 | 2018-07-03 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Executive Chairman | 595,460 | — | — | $20.0K | 4 | 2018-06-18 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Director | — | — | — | $0 | 7 | 2017-01-05 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Chief Executive Officer | 396,999 | — | — | $0 | 13 | 2016-06-27 |
| CALLISTO PHARMACEUTICALS INC (KAL) Delisted | Chief Executive Officer | 147,425 | $1.12 | $165.1K | $0 | 2 | 2007-10-25 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-21 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | OKYO | Buy (P) | +12,500 | $50.0K | EDGAR |
| 2022-01-05 | VRPX | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | CRDF | Other (J) | — | $0 | EDGAR |
| 2021-05-20 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2021-04-09 | VRPX | Grant (A) | — | $0 | EDGAR |
| 2021-03-23 | CRDF | Buy (P) | +2,370 | $24.7K | EDGAR |
| 2021-02-19 | VRPX | Buy (P) | +3,500 | $23.8K | EDGAR |
| 2020-12-01 | HEPA | Buy (P) | +12,000 | $19.9K | EDGAR |
| 2020-08-21 | HEPA | Grant (A) | — | $0 | EDGAR |